anti-midkine mAbs (Lyramid/Cellmid)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-midkine mAbs (Lyramid/Cellmid)
Drug Alias Nameanti-midkine monoclonal antibodies (Lyramid/Cellmid)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMidkine inhibitors
TargetsMidkine
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnagenics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnagenics Ltd
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A